Skip to content

IOVANCE BIOTHERAPEUTICS, INC.: filings

Every IOVANCE BIOTHERAPEUTICS, INC. annual and quarterly report in the SEC record with the published financial measures it tagged, 61 filings, each linked to its SEC index.

Filings with published measures

Each page shows what one filing reported, as tagged in that filing, with the periods it covered. Later filings can restate a value; the company overview shows the latest-filed value per period.

FormFiledFiscal periodMeasuresFactsSEC accession
10-Q2026-08-06fiscal Q2 2026501370001104659-26-091716
10-Q2026-05-07fiscal Q1 2026501050001104659-26-056778
10-K2026-02-24fiscal FY 2025521350001104659-26-018899
10-Q2025-11-06fiscal Q3 2025481310001104659-25-107470
10-Q2025-08-07fiscal Q2 2025501400001558370-25-010807
10-Q2025-05-08fiscal Q1 2025501050001558370-25-007009
10-K2025-02-27fiscal FY 2024511260001558370-25-001834
10-Q2024-11-07fiscal Q3 2024501390001558370-24-014905
10-Q2024-08-08fiscal Q2 2024501390001558370-24-011641
10-Q2024-05-09fiscal Q1 2024501030001558370-24-007646
10-K2024-02-28fiscal FY 2023511170001558370-24-002036
10-Q2023-11-07fiscal Q3 2023481260001558370-23-018029
10-Q2023-08-08fiscal Q2 2023511310001558370-23-013988
10-Q2023-05-10fiscal Q1 202340850001558370-23-009134
10-K2023-02-28fiscal FY 2022411060001558370-23-002419
10-Q2022-11-03fiscal Q3 2022401110001558370-22-016295
10-Q2022-08-04fiscal Q2 2022401110001558370-22-012263
10-Q2022-05-05fiscal Q1 202240850001558370-22-007449
10-K2022-02-24fiscal FY 2021421060001558370-22-001976
10-Q2021-11-04fiscal Q3 2021411120001558370-21-014670
10-Q2021-08-05fiscal Q2 2021391040001558370-21-010617
10-Q2021-05-06fiscal Q1 202137770001558370-21-006301
10-K2021-02-25fiscal FY 2020391080001558370-21-001858
10-Q2020-11-05fiscal Q3 202034910001558370-20-012946
10-Q2020-08-06fiscal Q2 202034910001104659-20-091526
10-Q2020-05-05fiscal Q1 202033730001104659-20-056994
10-K2020-02-25fiscal FY 2019391030001104659-20-024830
10-Q2019-11-04fiscal Q3 201934880001104659-19-059564
10-Q2019-08-01fiscal Q2 201934890001144204-19-037248
10-Q2019-05-07fiscal Q1 201933720001144204-19-024279
10-K2019-02-28fiscal FY 2018381150001144204-19-010702
10-Q2018-11-06fiscal Q3 201828740001144204-18-057663
10-Q2018-08-07fiscal Q2 201828740001144204-18-042241
10-Q2018-05-10fiscal Q1 201827560001144204-18-026764
10-K2018-03-12fiscal FY 2017361120001144204-18-014151
10-Q2017-11-02fiscal Q3 201732850001144204-17-055799
10-Q2017-08-03fiscal Q2 201728740001144204-17-040380
10-Q2017-05-03fiscal Q1 201727560001144204-17-024234
10-K2017-03-09fiscal FY 201632990001144204-17-013535
10-Q2016-11-04fiscal Q3 201623640001144204-16-131686
10-Q2016-08-09fiscal Q2 201623620001144204-16-117596
10-Q2016-05-09fiscal Q1 201623480001144204-16-099858
10-K2016-03-11fiscal FY 201528900001144204-16-087506
10-Q2015-11-06fiscal Q3 201523600001144204-15-063327
10-Q2015-08-10fiscal Q2 201521530001144204-15-047780
10-Q2015-05-11fiscal Q1 201520420001144204-15-029130
10-K2015-03-16fiscal FY 201429610001144204-15-016315
10-Q2014-11-13fiscal Q3 201424630001513160-14-000060
10-Q2014-08-08fiscal Q2 201424630001513160-14-000039
10-Q2014-05-14fiscal Q1 201425560001354488-14-002559
10-K2014-03-28fiscal FY 201324710001513160-14-000023
10-Q2013-11-14fiscal Q3 201324690001513160-13-000069
10-Q2013-10-23fiscal Q2 201324700001513160-13-000062
10-Q2013-10-23fiscal Q1 201323610001513160-13-000061
10-K2013-09-23fiscal FY 201224670001513160-13-000055
10-Q2013-01-25fiscal Q3 201223740001513160-13-000022
10-Q/A2012-09-10fiscal Q2 201223680001513160-12-000063
10-Q2012-05-15fiscal Q1 201223600001513160-12-000038
10-K2012-03-30fiscal FY 201122760001144204-12-018611
10-Q2011-11-21fiscal Q3 201121650001144204-11-066214
10-Q/A2011-09-01fiscal Q2 201119550001144204-11-050977

Inspect the source

Entity
IOVANCE BIOTHERAPEUTICS, INC. / CIK 0001425205
Captured
2026-09-20T08:03:45.999Z
SEC response SHA-256
bb58496635d85ba57e1fe3f80d062d09fbf1db1b6d80eb6e8ba8eda9321f7680

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001425205.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))